← Leaderboards
Claude-Henry Volmar
University Of Miami School Of Medicine
$1,918,802
Attributed
$3,837,603
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $751.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,837,603 · 3
By mechanism
R01$1,853,399 · 1
R56$1,478,559 · 1
R25$505,645 · 1
Top collaborators
- Claes Robert Wahlestedt6 shared
- Priyamvada Rai2 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Kent Lai$4,516,081
- Priyamvada Rai$4,728,635
- Jessica Lee Dennison$93,968
- Daniel Isom$3,868,604
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBiological MarkersNeuronsGenetic TranscriptionLinkNetwork ModelsEpigenetic ProcessBiobankFunctional DisorderGenesInsulin ResistanceAgingMolecularNerve DegenerationCoupledFloridaDementiaDetectionAffectChromatinGenomeFutureBrainPharmaceutical Preparations
Grant awards (8)
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$442,569
R01 · FY2025 · AG
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$212,386
R25 · FY2025 · CA
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$458,061
R01 · FY2024 · AG
Comprehensive Research Experiences to Advance Training and Education (CREATE) for Future Cancer Researchers$293,259
R25 · FY2024 · CA
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$465,894
R01 · FY2023 · AG
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$486,875
R01 · FY2022 · AG
Leveraging the Human Non-Coding Transcriptome to Identify Therapeutics for Healthy Aging and Alzheimers Disease$728,812
R56 · FY2019 · AG
Leveraging the Human Non-Coding Transcriptome to Identify Therapeutics for Healthy Aging and Alzheimers Disease$749,747
R56 · FY2018 · AG